Eli Lilly Makes Another In Vivo Genetic Medicines Move With $3.2B Kelonia AcquisitionNews DeskApril 20, 20260 Eli Lilly is expanding its reach in genetic medicines with a multi-billion dollar deal to acquire Kelonia Therapeutics, a startup…